The new AASLD guidance for #NAFLD are here! 2023 also started with pos phase 3 RCT. data. Congrats @marurinella et al #livertwitter #MedTwitter @drmoutaz @AASLDPresident @AASLDtweets @AASLDFoundation
Mazen Noureddin, MD, MHSc
2,235 posts
Mazen Noureddin, MD, MHSc
@NoureddinMD
Prof of Med, Hepatologist @Methodisthosp. Researcher, Dir Houston Research Institute. Father to 2 girls. AE @AGA_CGH
Houston, TX
Joined November 2016
- RIP big brother! Stephen last few days were filled with what he loved most. He was writing a piece about Resmetirom use and was pushing it w his close friends throughout the weekend. He passed from natural causes on Tuesday. His legacy will continue and we will all miss him
- My heart and prayers go out to the people from my city #Aleppo who were hit with the earthquake. Growing up I have never imagined this city and country will go through so many tragedies 🥹. @AlkhouriNaim @NoureddinNabil #aleppo_earthquake #Syria_earthquake #Syria @cnnbrk
- Here is the new nomenclature for #nafld ! Presented at @DDW2023 @AlkhouriNaim @AASLDtweets @EASLnews @AGA_CGH @JonathanStineMD @nagachalasani @AlinaAllenMD @marurinella @phil_newsome7 #livertwitter
- @AlkhouriNaim becomes a fellow of the @AASLDtweets the highest honor of our society! Congrats. @LiverArizona @AlinaAllenMD @NoureddinNabil @schattenbergJ @ebtapper @NASH_and_coffee #TLM22
- Life is unfair😢This is a devastating heartbreaking day to our hepatology community. Keep our friend and colleague @VinaySundaramMD in your prayers! #livertwitter @AASLDtweets @DrLiver @KowdleyMd @AlkhouriNaim @RajivJalan1 @rajVuppaLanchi @AsraniSumeet @lilydaramd @ArpanPatelMD
- Hot off the Press: The Most Important MASH phase 3 RCT hopefully leading to first Drug approval for MASH is out #livertwitter
- Hot off the press: Survodutide efficacy in#MASH including both MASH resolution & fibrosis improvement presented @EASLedu and published @NEJM today! @ArunJSanyalVCU @AlkhouriNaim @RamyYounes9 #livertwitter
- My parents and I have not seen my brother for 5 years. We haven’t met his first son. They were not allowed! My mom dad and all of us are full of hope today to see them soon. @JoeBiden @KamalaHarris #ban #dignity
- 💡Our New Paper in #hepatology using Machine learning to predict various stages of #NASH and #NASH fibrosis. #ML models did better than Conventional NITs including #fibroscan pubmed.ncbi.nlm.nih.gov/35809234/ #livertwitter @AASLDtweets @EASLnews @LITMUS_IMI @AlkhouriNaim @schattenbergJ
- Fatty liver is still under diagnosed and many patients present for the first time with cirrhosis 👎🏻. Screening in diabetics & overweight people should be started. International NASH day June 12. #livertwitter #NAFLD #MedTwitter @intNASHday @NAFLDSupport @GlobalLiver @NASH_AWARE
- #Resmetirom is the first FDA drug to be approved for NASH/MASH patients without cirrhosis! #livertwitter it took long years but what a rewarding journey for those who were part of it! Happy for our patients. More work to be done @MadrigalPharma @AASLDtweets @HMethodistMDImportant day for hepatology - 1st ever medication approved for #MASH #NASH! Resmetirom approved by @US_FDA for people with MASH & fibrosis but no cirrhosis. Let's hope the promise shown in clinical trials will hold in real life outcomes. #livertwitter fda.gov/news-events/pr…
- 🔥Breaking News: Madrigal Announces Positive Topline Results from the Pivotal Phase 3 MAESTRO-NASH Trial of Resmetirom for NASH and Liver Fibrosis. #livertwitter @AlkhouriNaim @NASH_and_coffee @AlinaAllenMD @ebtapper @novonordisk @Madrigal @akerotx #GITwitter @AleksanderKrag
